Three novel tumor-derived exosome genes, insulin‐like growth factor binding protein 6 (IGFBP6), VGF (non-acronym), and T-cell Receptor Constant β Chain-1 (TRBC1), which significantly affected the risk score, were also identified. This evidence concerns the gene IGFBP6 and neoplasm.